BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35933565)

  • 1. RNF2 mediates pulmonary fibroblasts activation and proliferation by regulating mTOR and p16-CDK4-Rb1 signaling pathway.
    Pan L; Hu Y; Qian C; Yao Y; Wang S; Shi W; Xu T
    Inflamm Res; 2022 Nov; 71(10-11):1283-1303. PubMed ID: 35933565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression.
    Lan YJ; Cheng MH; Ji HM; Bi YQ; Han YY; Yang CY; Gu X; Gao J; Dong HL
    Acta Pharmacol Sin; 2023 May; 44(5):1029-1037. PubMed ID: 36333557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells.
    He J; Peng H; Wang M; Liu Y; Guo X; Wang B; Dai L; Cheng X; Meng Z; Yuan L; Cai F; Tang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):810-820. PubMed ID: 32638014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF2 Mediates Hepatic Stellate Cells Activation by Regulating ERK/p38 Signaling Pathway in LX-2 Cells.
    Yan Q; Pan L; Qi S; Liu F; Wang Z; Qian C; Chen L; Du J
    Front Cell Dev Biol; 2021; 9():634902. PubMed ID: 33816485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
    Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
    Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
    Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
    Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rehmannia Radix Extract Relieves Bleomycin-Induced Pulmonary Fibrosis in Mice via Transforming Growth Factor β1 (TGF-β1).
    Hu X; Zhu D
    Med Sci Monit; 2020 Dec; 26():e927240. PubMed ID: 33259471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.
    Zhou Y; Koli K; Hagood JS; Miao M; Mavalli M; Rifkin DB; Murphy-Ullrich JE
    Am J Pathol; 2009 Jan; 174(1):21-33. PubMed ID: 19056849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
    Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bletilla striata polysaccharide attenuated the progression of pulmonary fibrosis by inhibiting TGF-β1/Smad signaling pathway.
    Wang S; Yu J; Liu Y; Yu J; Ma Y; Zhou L; Liu X; Liu L; Li W; Niu X
    J Ethnopharmacol; 2024 Apr; 323():117680. PubMed ID: 38171465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
    Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
    Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV restrains pulmonary fibrosis progression via the circ_0008898/miR-211-5p/HMGB1 axis.
    Zhu M; Zhao L; Zhang X; Zhao R
    Chem Biol Drug Des; 2024 Mar; 103(3):e14508. PubMed ID: 38514749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling.
    Li J; Li K; Tian Y; Zhao P; Liu X; Li M; Bai Y
    Phytomedicine; 2023 Jan; 109():154604. PubMed ID: 36610143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
    Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway.
    Zhang Y; Yao XH; Wu Y; Cao GK; Han D
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8483-8492. PubMed ID: 32894569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.